TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$20.20
-5.47% today
Updated 2026-04-29
Market cap
$2.61B
P/E ratio
—
P/S ratio
4.05x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$8 – $26
Volume
2.4M
10X Genomics Inc (TXG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.08M | $146.31M | $245.89M | $298.85M | $490.49M | $516.41M | $618.73M | $610.78M | $642.82M |
| Revenue growth (YoY) | — | +105.8% | +68.1% | +21.5% | +64.1% | +5.3% | +19.8% | -1.3% | +5.2% |
| Cost of revenue | $10.56M | $28.66M | $61.03M | $58.47M | $74.09M | $120.39M | $209.41M | $196.30M | $198.94M |
| Gross profit | $60.52M | $117.65M | $184.86M | $240.38M | $416.40M | $396.02M | $409.31M | $414.48M | $443.88M |
| Gross margin | 85.1% | 80.4% | 75.2% | 80.4% | 84.9% | 76.7% | 66.2% | 67.9% | 69.1% |
| R&D | $32.16M | $47.54M | $83.10M | $123.38M | $211.75M | $265.67M | $270.33M | $264.70M | $238.63M |
| SG&A | $46.54M | $87.24M | $129.33M | $200.43M | $252.86M | $294.60M | $340.03M | $339.34M | $316.13M |
| Operating income | $-18.38M | $-110.76M | $-29.07M | $-85.32M | $-52.91M | $-167.94M | $-265.33M | $-194.56M | $-110.89M |
| Operating margin | -25.8% | -75.7% | -11.8% | -28.6% | -10.8% | -32.5% | -42.9% | -31.9% | -17.2% |
| EBITDA | $-13.63M | $-106.08M | $-20.89M | $-513.77M | $-24.59M | $-128.49M | $-205.11M | $-133.99M | $-110.89M |
| EBITDA margin | -19.2% | -72.5% | -8.5% | -171.9% | -5.0% | -24.9% | -33.2% | -21.9% | -17.2% |
| EBIT | $-17.93M | $-109.99M | $-27.95M | $-532.79M | $-52.85M | $-161.50M | $-248.73M | $-177.70M | — |
| Interest expense | $811000.00 | $2.41M | $3.08M | $1.68M | $866000.00 | $476000.00 | $33000.00 | $4000.00 | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-18.76M | $-112.48M | $-31.25M | $-542.73M | $-58.22M | $-166.00M | $-255.10M | $-182.63M | $-43.54M |
| Net income growth (YoY) | — | -499.5% | +72.2% | -1636.7% | +89.3% | -185.1% | -53.7% | +28.4% | +76.2% |
| Profit margin | -26.4% | -76.9% | -12.7% | -181.6% | -11.9% | -32.1% | -41.2% | -29.9% | -6.8% |